Synthesis and stereoselective DNA binding abilities of new optically active open-chain polyamines

Journal of Organic Chemistry

Volumn 72, Issue 6, 2007, Pages 1924-1930

  Peña, Carmen ^a   Alfonso, Ignacio ^b   Tooth, Blake ^c   Voelcker, Nicolas H ^c   Gotor, Vicente ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITAT JAUME I   (Spain)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; DNA SEQUENCES; MELTING POINT; STEREOSELECTIVITY; SYNTHESIS (CHEMICAL);

CYCLOHEXANEDIAMINE; DNA BINDING ABILITIES; FUNCTIONALIZATION; POLYAMINES;

ORGANIC POLYMERS;

CYCLOHEXANE DERIVATIVE; DIAMINE DERIVATIVE; POLYAMINE DERIVATIVE; SULFONAMIDE;

ALKYLATION; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DNA BINDING; OPTICAL ROTATION; STEREOCHEMISTRY; SYNTHESIS; TEMPERATURE; ULTRAVIOLET SPECTROSCOPY;

ALKYLATION; BINDING SITES; CYCLOHEXYLAMINES; DNA; NUCLEIC ACID DENATURATION; POLYAMINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 33947268196     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0619837     Document Type: Article

References (65)

1. (a) Campbell, D. R.; Morris, D. R.; Bartos, D.; Daves, G. D., Jr.; Bartos, F. Advances in Polyamine Research; Raven Press: New York, 1978.
2. (b) Goldenburg, S. H.; Algranati, J. D. The Biology and Chemistry of Polyamines; JCSU Press: Oxford, 1990.
3. For some recent revisions on polyamine synthesis, see: (c) Bender, J. A.; Meanwell, N. A.; Wang, T. Tetrahedron 2002, 58, 3111.
4. (d) Kuksa, V.; Buchan, R.; Lin, P. K. T. Synthesis 2000, 1189.
5. (e) Karigiannis, G.; Papaioannou, D. Eur. J. Org. Chem. 2000, 1841.
6. (a) Tabor, C. W.; Tabor, H. Annu. Rev. Biochem. 1984, 53, 749.
7. (b) Pegg, A. E. Biochem. J. 1986, 234, 249.
8. (c) Pegg, A. E. Cancer Res. 1988, 759.
9. (c) Schuber, F. Biochem. J. 1989, 260, 1.
10. (a) Bergeron, R. J.; Weimar, W. R.; Wu, Q.; Austin, J. K., Jr.; McManis, J. S. J. Med. Chem. 1995, 38, 425.
11. Bergeron, R. J.; Yao, G. W.; Yao, H.; Weimar, W. R.; Sninsky, R. B.; Feng, Y.; Wu, Q.; Gao, F. J. Med. Chem. 1996, 39, 2461.
12. (a) Casero, R. A.; Woster, P. M. J. Med. Chem. 2001, 44, 1.
13. (b) Zou, Y.; Wu, Z.; Sirisoma, N.; Woster, P. M.; Casera, R. A., Jr.; Weiss, L. M.; Rattendi, D.; Lane, S.; Bacchi, C. J. Bioorg. Med. Chem. Lett. 2001, 11, 1613.
14. (c) Gerner, E. W.; Meyskens, F. L. Nature Rev. Cancer 2004, 4, 781.
15. See, for instance: Lomadze, N.; Schneider, H.-J.; Albelda, M. T.; García-España, E.; Verdejo, B. Org. Biomol. Chem. 2006, 4, 1755 and references therein.
16. (a) Feurstein, B. G.; Patabhiraman, N.; Marton, L. J. Nucleic Acids Res. 1990, 18, 1271.
17. (b) Delcros, J. G.; Strukenboom, C. J. M.; Basu, H. S.; Shafer, R. H.; Szollosi, J.; Feuerstein, B. G.; Marton, L. J. Biochem. J. 1993, 291, 269.
18. (a) Bancroft, D.; Williams, L. D.; Rich, A.; Egli, M. Biochemistry 1994, 33, 1073.
19. (b) Korolev, N.; Lyubartsev, A. P.; Nordenskiöld, L.; Laaksonen, A. J. Mol. Biol. 2001, 308, 907.
20. (a) Ganem, B. Acc. Chem. Res. 1982, 15, 290.
21. (b) Bergeron, R. J. Acc. Chem. Res. 1986, 19, 105.
22. Sukhanova, A.; Dêvy, J.; Pluot, M.; Bradley, J.-C.; Vigneron, J.-P.; Jardillier, J.-C.; Lehn, J.-M.; Nabiev, I. Bioorg. Med. Chem. 2001, 9, 1255.
23. Krämer, M.; Stumbé, J.-F.; Grimm, G.; Kaufmann, B.; Krüger, U.; Weber, M.; Haag, R. ChemBioChem 2004, 5, 1081.
24. (a) Rajeev, K. G.; Sanjayan, G. J.; Ganesh, K. N. J. Org. Chem. 1997, 62, 5169.
25. (b) Reddy, V. K.; Valasinas, A.; Sarkar, A.; Basu, H. S.; Marton, L. J.; Frydman, B. J. Med. Chem. 1998, 41, 4723.
26. (c) Valasinas, A.; Sarcar, A.; Reddy, V. K.; Marton, L. J.; Basu, H. S.; Frydman, B. J. Med. Chem. 2001, 44, 390.
27. Nagamani, D.; Ganesh, K. Org. Lett. 2001, 3, 103.
28. (a) Tsubaki, K.; Kusumoto, T.; Hayashi, N.; Tanima, D.; Fuji, K.; Kawabata, T. Tetrahedron: Asymmetry 2005, 16, 739.
29. (b) Nefzi, A.; Ostresh, J. M.; Yu, J.; Houghten, R. A. J. Org. Chem. 2004, 69, 3603.
30. Manku, S.; Laplante, C.; Kopac, D.; Chan, T.; Hall, D. G. J. Org. Chem. 2001, 66, 874.
31. Peña, C.; Alfonso, I.; Voelcker, N. H.; Gotor, V. Tetrahedron Lett. 2005, 46, 2783.
32. Peña, C.; Alfonso, I.; Gotor, V. Eur. J. Org. Chem. 2006, 3887.
33. (a) Bru, M.; Alfonso, I.; Burguete, M. I.; Luis, S. V. Tetrahedron Lett. 2005, 46, 7781.
34. (b) González-Alvarez, A.; Alfonso, I.; López-Ortiz, F.; Aguirre, A.; García-Granda, S.; Gotor V. Eur. J. Org. Chem. 2004, 1117.
35. (c) Fitzsimmons, P. M.; Jackels, S. C. Inorg. ChIm. Acta 1996, 246, 301.
36. Saenger, W. Principles of Nucleic Acids. Springer-Verlag: New York, 1984.
37. (a) Ha, S. C.; Lowenhaupt, K.; Rich, A.; Kim, Y.-G.; Nim, K. K. Nature 2005, 437, 1183.
38. (b) Lewis, F. D.; Zhang, L.; Liu, X.; Zuo, X.; Tiede, D. M.; Long, H.; Schatz, G. C. J. Am. Chem. Soc. 2005, 127, 14445.
39. (c) Mao, C.; Sun, W.; Shen, Z.; Seeman, N. C. Nature 1999, 397, 144.
40. (d) Erlanson, D. A.; Glover, J. N. M.; Verdine, G. L. J. Am. Chem. Soc. 1997, 119, 6927.
41. (e) Saenger, W.; Hunter, W. N.; Kennard, O. Nature 1986, 324, 385.
42. (a) Wang, G.; Christensen, L. A.; Vasquez, K. M. Proc. Nat. Acad. Sci. U.S.A. 2006, 103, 2677.
43. (b) Waring, M. Proc. Nat. Acad. Sci. U.S.A. 2000, 97, 11685.
44. (c) Otokiti, E. O.; Sheardy, R. D. Biochemistry 1997, 36, 11419.
45. Misra, V. K.; Honig, B. Biochemistry 1996, 35, 1115.
46. (e) Sheardy, R. D.; Levine, N.; Marotta, S.; Suh, D.; Chaires, J. B. Biochemistry 1994, 33, 1385.
47. (f) Hardin, C. C.; Walker, G. T.; Tinoco, I., Jr. Biochemistry 1988, 27, 4178.
48. (g) Walker, G. T.; Stone, M. P.; Krugh, T. R. Biochemistry 1985, 24, 7471.
49. (a) González-Álvarez, A.; Alfonso, I.; Díaz, P.; García-España, E.; Gotor, V. Chem. Commun. 2006, 1227.
50. (b) Alfonso, L; Dietrich, B.; Rebolledo, F.; Gotor, V.; Lehn, J. M. Helv. Chim. Acta 2001, 280.
51. Alfonso, I.; Rebolledo, F.; Gotor, V. Chem. Eur. J. 2000, 6, 3331.
52. For some recent examples, see: (a) Gaudry, E.; Aubard, J.; Amouri, H.; Levi, G.; Cordier, C. Biopolymers 2006, 82, 399.
53. (b) Xu, Y.; Zhang, Y. X.; Sugiyama, H.; Umano, T.; Osuga, H.; Tanaka, K. J. Am. Chem. Soc. 2004, 126, 6566.
54. (c) Smith, J. A.; Collins, J. G.; Patterson, B. T.; Keene, F. R. Dalton Trans. 2004, 1277.
55. (d) Zinchenko, A. A., Sergeyev, V. G.; Kabanov, V. A.; Murata, S.; Yoshikawa, K. Angew. Chem., Int. Ed. 2004, 43, 2378.
56. (e) Munk, V. P.; Diakos, C. I.; Messerle, B. A.; Fenton, R. R.; Hambley, T. W. Chem. Eur. J. 2002, 8, 5486.
57. (f) Honzawa, S.; Okubo, H.; Anzai, S.; Yamaguchi, M.; Tsumono, K.; Kumagai, I. Bioorg. Med. Chem. 2002, 10, 3213.
58. (g) Ji, L.-N.; Zou, X.-H.; Liu, J.-G. Coord. Chem. Rev. 2001, 216, 513.
59. (h) Becker, H.-C.; Norden, B. J. Am. Chem. Soc. 2000, 122, 8344.
60. Bianchi, A.; Bowman-James, K.; García-España, E. Supramolecular Chemistry of Anions; VCH: Weinheim, 1997.
61. (a) Kirby, A. J.; Camillery, P.; Engberts, J. B. F. N.; Feiters, M. C.; Nolle, R. J. M.; Söderman, O.; Bergsma, M.; Bell, P. C.; Fielden, M. L.; García-Rodríguez, C.; Guédat, P.; Kremer, A.; McGregor, C.; Perrin, C.; Ronsin, G.; van Eijk, M. C. P. Angew. Chem., Int. Ed. 2003, 42, 1448.
62. (b) Luo, D.; Saltzman, W. M. Nature Biotech. 2000, 18, 33.
63. For some recent revisions, see: (a) Huang, Y.; Pledgie, A.; Casero, R. A., Jr.; Davidson, N. E. Anti-Cancer Drug 2005, 16, 229.
64. (b) Moinard, C.; Cynober, L.; Bandt, J.-P. Clin. Nutr. 2005, 24, 184.
65. (c) Seiler, N. Curr. Drug Targets 2003, 4, 565.